BUPROPION HCl RETARD TEVA

Medicinal product

(Invented) name

BUPROPION HCl RETARD TEVA

Active substance (s)

Bupropiono hidrochloridas

Strength

150 mg

Pharmaceutical form

modifikuoto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N06AX12, Bupropion

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-05-02

Date of renewal

Documents

2539_BUPROPION_HCl_RETARD_TEVA_150mg_mod_atp_tab_PIL_2025-05-02.docx

2539_BUPROPION_HCl_RETARD_TEVA_150mg_mod_atp_tab_PZ_2025-05-02.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Bupropiono hidrochloridas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117439	103544	1103544	buteliukas	N30		Receptinis	LT/L/25/2539/001	Netiekiama	-	2025-07-05	No	-	-	Download

Stadijos

Data	Stadija
2025-05-02	Registruotas